Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria W Dayer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 26, 2025
Defining a Framework for Sustainable Global Biosimilars Markets Using Findings from a Targeted Literature ReviewJoshua A Roth, Victoria W Dayer, Mireia Jofre-Bonet, et al.
Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Patient out-of-pocket costs and rheumatology biosimilar competitionVictoria W Dayer, Ryan N Hansen, Joshua Roth, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 23, 2025
Comprehensive Access to Semaglutide: Clinical and Economic Implications for MedicareVictoria W Dayer, Iman Nourhussein, Adam Kasle, et al.
JACC. Advances|August 12, 2024
Long-Term Outcomes of Heart Failure With Preserved or Mid-Range Ejection Fraction in the United StatesLucille A Sun, Victoria W Dayer, Ryan N Hansen, et al.
Orphanet Journal of Rare Diseases|February 7, 2024
Real-world evidence for coverage determination of treatments for rare diseasesVictoria W Dayer, Michael F Drummond, Omar Dabbous, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 26, 2025
Defining a Framework for Sustainable Global Biosimilars Markets Using Findings from a Targeted Literature ReviewJoshua A Roth, Victoria W Dayer, Mireia Jofre-Bonet, et al.
Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Patient out-of-pocket costs and rheumatology biosimilar competitionVictoria W Dayer, Ryan N Hansen, Joshua Roth, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 23, 2025
Comprehensive Access to Semaglutide: Clinical and Economic Implications for MedicareVictoria W Dayer, Iman Nourhussein, Adam Kasle, et al.
JACC. Advances|August 12, 2024
Long-Term Outcomes of Heart Failure With Preserved or Mid-Range Ejection Fraction in the United StatesLucille A Sun, Victoria W Dayer, Ryan N Hansen, et al.
Orphanet Journal of Rare Diseases|February 7, 2024
Real-world evidence for coverage determination of treatments for rare diseasesVictoria W Dayer, Michael F Drummond, Omar Dabbous, et al.
Pageof 1